Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives
- 21 July 2017
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 26 (11) , 2889-2899
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research (File No. 08/590(0001)/2012-EMR-I)
- University Grants Commission (UGC No. 42355(SR)/2013)
This publication has 31 references indexed in Scilit:
- Design, synthesis and anticonvulsant evaluation of N-(benzo[d]thiazol-2-ylcarbamoyl)-2-methyl-4-oxoquinazoline-3(4H)-carbothioamide derivatives: A hybrid pharmacophore approachEuropean Journal of Medicinal Chemistry, 2013
- Bithiazole Correctors Rescue CFTR Mutants by Two Different MechanismsBiochemistry, 2013
- Synthesis and biological evaluation of some novel thiazole substituted benzotriazole derivativesBioorganic & Medicinal Chemistry Letters, 2012
- A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agentsJournal of Microbiological Methods, 2011
- Potential of Cameroonian Plants and Derived Products against Microbial Infections: A ReviewPlanta Medica, 2010
- Triazole incorporated thiazoles as a new class of anticonvulsants: Design, synthesis and in vivo screeningEuropean Journal of Medicinal Chemistry, 2010
- A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilliJournal of Microbiological Methods, 2008
- Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoproteinTuberculosis, 2007
- Global Incidence of Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2006
- In vitro evaluation of cell/biomaterial interaction by MTT assayBiomaterials, 1993